References
- FileTMMarrieTJBurden of community-acquired pneumonia in North American adultsPostgrad Med2010122213014120203464
- MarrieTJShariatzadehMRCommunity-acquired pneumonia requiring admission to an intensive care unit: a descriptive studyMedicine (Baltimore)200786210311117435590
- RestrepoMIMortensenEMRelloJBrodyJAnzuetoALate admission to the ICU in patients with community-acquired pneumonia is associated with higher mortalityChest2010137355255719880910
- DíazLAMortensenEMAnzuetoARestrepoMINovel targets in the management of pneumoniaTher Adv Respir Dis20082638740019124384
- MandellLAWunderinkRGAnzuetoAInfectious Diseases Society of AmericaAmerican Thoracic SocietyInfectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adultsClin Infect Dis200744Suppl 2S27S7217278083
- IshikawaTMatsunagaNTawadaHTAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological propertiesBioorg Med Chem200311112427243712735989
- SaderHSFritscheTRKanigaKGeYJonesRNAntimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strainsAntimicrob Agents Chemother20054983501351216048970
- MushtaqSWarnerMGeYKanigaKLivermoreDMIn vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypesJ Antimicrob Chemother200760230031117548456
- WatkinsRRLemonovichTLDiagnosis and management of community-acquired pneumonia in adultsAm Fam Physician201183111299130621661712
- MoisanHPruneauMMalouinFBinding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniaeJ Antimicrob Chemother201065471371620097788
- Teflaro® (ceftaroline fosamil) injection for intravenous (IV) use [package insert]St Louis, MOForest Laboratories, Inc2013 Available from: http://www.frx.com/pi/teflaro_pi.pdfAccessed March 11, 2014
- FileTMLowDEEckburgPBIntegrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter Phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumoniaClin Infect Dis201051121395140521067350
- FileTMJrLowDEEckburgPBFOCUS 1 Investigators. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaJ Antimicrob Chemother201166Suppl 3iii19iii3221482566
- LowDEFileTMJrEckburgPBFOCUS 2 Investigators. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaJ Antimicrob Chemother201166Suppl 3iii33iii4421482568
- RankDRFriedlandHDLaudanoJBIntegrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumoniaJ Antimicrob Chemother201166Suppl 3iii53iii5921482570
- International Conference on HarmonisationGuidance for Industry. E6 Good Clinical Practice: Consolidated GuidanceRockville, MDDrug Information Branch (HFD-210), Center for Drug Evaluation and Research (CDER)1996 Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm073122.pdfAccessed March 11, 2014
- RestrepoMIMortensenEMVelezJAFreiCAnzuetoAA comparative study of community-acquired pneumonia patients admitted to the ward and the ICUChest2008133361061717989157
- RestrepoMIAnzuetoASevere community-acquired pneumoniaInfect Dis Clin North Am200923350352019665080
- FineMJAubleTEYealyDMA prediction rule to identify low-risk patients with community-acquired pneumoniaN Engl J Med199733642432508995086
- BartlettJGDiagnostic tests for agents of community-acquired pneumoniaClin Infect Dis201152Suppl 4S296S30421460288
- FileTMSrinivasanABartlettJGAntimicrobial stewardship: importance for patient and public healthClin Infect Dis201459Suppl 3S93S9625261547
- LeroyOSauxPBédosJPCaulinEComparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressorsChest2005128117218316002932
- BlaschkeAJInterpreting assays for the detection of Streptococcus pneumoniaeClin Infect Dis201152Suppl 4S331S33721460292